Vanguard Group’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $12.2M | Buy |
|
|||||
|
2025
Q2 | $15.7M | Buy |
|
|||||
|
2025
Q1 | $18.7M | Sell |
|
|||||
|
2024
Q4 | $31.1M | Sell |
|
|||||
|
2024
Q3 | $37.3M | Buy |
|
|||||
|
2024
Q2 | $28.9M | Buy |
|
|||||
|
2024
Q1 | $33.7M | Sell |
|
|||||
|
2023
Q4 | $51M | Sell |
|
|||||
|
2023
Q3 | $65.2M | Buy |
|
|||||
|
2023
Q2 | $79.5M | Buy |
|
|||||
|
2023
Q1 | $72.3M | Buy |
|
|||||
|
2022
Q4 | $64.5M | Buy |
|
|||||
|
2022
Q3 | $57.6M | Buy |
|
|||||
|
2022
Q2 | $76.9M | Buy |
|
|||||
|
2022
Q1 | $111M | Sell |
|
|||||
|
2021
Q4 | $170M | Buy |
|
|||||
|
2021
Q3 | $206M | Buy |
|
|||||
|
2021
Q2 | $194M | Buy |
|
|||||
|
2021
Q1 | $139M | Buy |
|
|||||
|
2020
Q4 | $126M | Buy |
|
|||||
|
2020
Q3 | $95.8M | Buy |
|
|||||
|
2020
Q2 | $60.2M | Buy |
|
|||||
|
2020
Q1 | $23.3M | Buy |
|
|||||
|
2019
Q4 | $27.5M | Buy |
|
|||||
|
2019
Q3 | $23M | Buy |
|